Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Among the genes most commonly identified in gene expression profiles of epithelial ovarian carcinomas (EOC) is the gene for human epididymis protein 4 (HE4). To ascertain its clinical utility, we did a comprehensive assessment of HE4 protein expression in benign and malignant ovarian and nonovarian tissues by immunohistochemistry. In comparison with normal surface epithelium, which does not express HE4, we found that cortical inclusion cysts lined by metaplastic Mullerian epithelium abundantly express the protein. Its expression in tumors was restricted to certain histologic subtype: 93% of serous and 100% of endometrioid EOCs expressed HE4, whereas only 50% and 0% of clear cell carcinomas and mucinous tumors, respectively, were positive. Tissue microarrays revealed that the majority of nonovarian carcinomas do not express HE4, consistent with our observation that HE4 protein expression is highly restricted in normal tissue to the reproductive tracts and respiratory epithelium. HE4 is predicted to encode a secreted protein. Using reverse transcription-PCR, we identified ovarian cancer cell lines that endogenously overexpress HE4. Cultured medium from these cells revealed a secreted form of HE4 that is N-glycosylated. This observation is consistent with the recent report that HE4 circulates in the bloodstream of patients with EOC. Therefore, HE4 is a secreted glycoprotein that is overexpressed by serous and endometrioid EOCs. Its expression in cortical inclusion cysts suggests that formation of Mullerian epithelium is a prerequisite step in the development of some types of EOCs.

[1]  Jinsong Liu,et al.  Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1 , 2003, Oncogene.

[2]  B. Stewart,et al.  World Cancer Report , 2003 .

[3]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. Lilja,et al.  A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein. , 2002, The Biochemical journal.

[5]  M. Dwek,et al.  Harnessing changes in cellular glycosylation in new cancer treatment strategies. , 2004, Current cancer drug targets.

[6]  M. Kiechle,et al.  Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation , 2001, Cancer.

[7]  K. Hamil,et al.  Cloning and sequencing of human Eppin: a novel family of protease inhibitors expressed in the epididymis and testis. , 2001, Gene.

[8]  R. Drapkin,et al.  Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. , 2004, Human pathology.

[9]  D. Pinkel,et al.  Genetic analysis of benign, low-grade, and high-grade ovarian tumors. , 1995, Cancer research.

[10]  T Tanaka,et al.  Identification by cDNA microarray of genes involved in ovarian carcinogenesis. , 2000, Cancer research.

[11]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Cody Schrank,et al.  American Cancer Society , 2005 .

[13]  S. Hakomori,et al.  Glycosylation defining cancer malignancy: New wine in an old bottle , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Orntoft,et al.  Clinical aspects of altered glycosylation of glycoproteins in cancer , 1999, Electrophoresis.

[15]  L. Bingle,et al.  The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms , 2002, Oncogene.

[16]  S. Mok,et al.  Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. , 2001, BioTechniques.

[17]  D R Schwartz,et al.  Coordinately up-regulated genes in ovarian cancer. , 2001, Cancer research.

[18]  C. Kirchhoff.  Molecular characterization of epididymal proteins. , 1998, Reviews of reproduction.

[19]  H. Katabuchi,et al.  Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. , 2001, Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia.

[20]  S. Skates,et al.  Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review , 2004, Disease markers.

[21]  Trevor Hastie,et al.  Gene expression patterns in ovarian carcinomas. , 2003, Molecular biology of the cell.

[22]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[23]  Michèl Schummer,et al.  The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. , 2003, Cancer research.

[24]  R. Drapkin,et al.  The origins of ovarian cancer : hurdles and progress , 2002 .

[25]  A. Godwin,et al.  Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas , 1997, Genes, chromosomes & cancer.

[26]  R. Ivell,et al.  A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. , 1991, Biology of reproduction.

[27]  Erming Tian,et al.  Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy , 2004, International journal of cancer.

[28]  R. Ozols,et al.  Focus on epithelial ovarian cancer. , 2004, Cancer cell.

[29]  R. Ozols,et al.  Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies , 2003, Cancer.

[30]  G. Riggins,et al.  Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. , 2000, Cancer research.

[31]  L. Hood,et al.  Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. , 1999, Gene.

[32]  Luigi Marchionni,et al.  Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 , 2004, Oncogene.

[33]  W. H. Kim,et al.  Establishment and characterization of human ovarian carcinoma cell lines. , 1997, Gynecologic oncology.

[34]  Eeva Kettunen,et al.  Changes in gene expression during progression of ovarian carcinoma , 2001, Cancer genetics and cytogenetics.

[35]  M. Wells,et al.  Precursor lesions of ovarian epithelial malignancy , 2001, Histopathology.

[36]  Chris Cheadle,et al.  Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. , 2002, Cancer research.

[37]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[38]  R. Bast,et al.  Status of tumor markers in ovarian cancer screening. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  Roger E Bumgarner,et al.  Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. , 1999, Gene.

[40]  Joan G. Jones,et al.  Expression of Calretinin in Human Ovary, Testis, and Ovarian Sex Cord-Stromal Tumors , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[41]  Anne-Marie Mes-Masson,et al.  Microarray analysis of gene expression mirrors the biology of an ovarian cancer model , 2001, Oncogene.